Abstract
AbstractVaccinia virus (VACV) is a prototypical poxvirus originally used for eradication of smallpox. Investigation into VACV mRNAs carried out almost half a century ago substantially contributed to the fundamental discovery of the 5’ mRNA cap, a hallmark of all eukaryotic and many viral mRNAs. VACV research also facilitated the identification and understanding of the general mechanism of 5’ mRNA cap synthesis. We characterized the VACV transcripts at the individual mRNA molecule level and found that vaccinia postreplicative mRNAs, containing nontemplated 5’ poly(A) leaders, surprisingly lack the 5’ cap structure in vivo. We also show that the lengths of the nontemplated leaders and the presence or absence of cap structures at the 5’ mRNA ends are controlled by the initiator sequence of the VACV postreplicative promoters.One Sentence SummaryThe promoter sequence determines the synthesis of the 5’ cap and poly(A) leaders in vaccinia virus postreplicative mRNAs.
Publisher
Cold Spring Harbor Laboratory
Reference33 articles.
1. Poxvirus tropism
2. Human Monkeypox: Epidemiologic and Clinical Characteristics, Diagnosis, and Prevention;Infect Dis Clin North Am,2019
3. WHO, Monkeypox - fact sheets. https://www.who.int/news-room/fact-sheets/detail/monkeypox, (2019).
4. C. R. MacIntyre , Reevaluating the Risk of Smallpox Reemergence. Military medicine, (May 6, 2020).
5. S. Melamed , T. Israely , N. Paran , Challenges and Achievements in Prevention and Treatment of Smallpox. Vaccines 6, (Jan 29, 2018).
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献